Lakefront Biotherapeutics

Belgian pharmaceutical company

LKFT Euronext Brussels · home listing GLPG Euronext Amsterdam GLPG Nasdaq ISIN BE0003818359 SEC CIK 1421876 LEI 549300QKJ78IY0IOV655
Follow Lakefront Biotherapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 EUR · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing